Literature DB >> 26400718

Relapsing encephalopathy with cerebellar ataxia related to an ATP1A3 mutation.

Rodolphe Dard1, Cyril Mignot1, Alexandra Durr1,2, Gaetan Lesca3, Damien Sanlaville3, Emmanuel Roze2,4, Fanny Mochel1,2,5.   

Abstract

ATP1A3, the gene encoding the α3-subunit of the Na(+) /K(+) -ATPase pump, has been involved in four clinical neurological entities: (1) alternating hemiplegia of childhood (AHC); (2) rapid-onset dystonia parkinsonism (RDP); (3) CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy, sensorineural hearing loss) syndrome; and (4) early infantile epileptic encephalopathy. Here, we report on a 34-year-old female presenting with a new ATP1A3-related entity involving a relapsing encephalopathy characterized by recurrent episodes of cerebellar ataxia and altered consciousness during febrile illnesses. The term RECA is suggested - relapsing encephalopathy with cerebellar ataxia. The phenotype of this patient, resembling mitochondrial oxidative phosphorylation defects, emphasizes the possible role of brain energy deficiency in patients with ATP1A3 mutations. Rather than multiple overlapping syndromes, ATP1A3-related disorders might be seen as a phenotypic continuum.
© 2015 Mac Keith Press.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26400718     DOI: 10.1111/dmcn.12927

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  34 in total

1.  Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition.

Authors:  Elena Arystarkhova; Ihtsham U Haq; Timothy Luebbert; Fanny Mochel; Rachel Saunders-Pullman; Susan B Bressman; Polina Feschenko; Cynthia Salazar; Jared F Cook; Scott Demarest; Allison Brashear; Laurie J Ozelius; Kathleen J Sweadner
Journal:  Neurobiol Dis       Date:  2019-08-16       Impact factor: 5.996

2.  Revising rapid-onset dystonia-parkinsonism: Broadening indications for ATP1A3 testing.

Authors:  Ihtsham U Haq; Beverly M Snively; Kathleen J Sweadner; Cynthia K Suerken; Jared F Cook; Laurie J Ozelius; Charlotte Miller; William V McCall; Christopher T Whitlow; Allison Brashear
Journal:  Mov Disord       Date:  2019-07-30       Impact factor: 10.338

3.  The CAPOS mutation in ATP1A3 alters Na/K-ATPase function and results in auditory neuropathy which has implications for management.

Authors:  Lisbeth Tranebjærg; Nicola Strenzke; Sture Lindholm; Nanna D Rendtorff; Hanne Poulsen; Himanshu Khandelia; Wojciech Kopec; Troels J Brünnich Lyngbye; Christian Hamel; Cecile Delettre; Beatrice Bocquet; Michael Bille; Hanne H Owen; Toke Bek; Hanne Jensen; Karen Østergaard; Claes Möller; Linda Luxon; Lucinda Carr; Louise Wilson; Kaukab Rajput; Tony Sirimanna; Katherine Harrop-Griffiths; Shamima Rahman; Barbara Vona; Julia Doll; Thomas Haaf; Oliver Bartsch; Hendrik Rosewich; Tobias Moser; Maria Bitner-Glindzicz
Journal:  Hum Genet       Date:  2018-01-05       Impact factor: 4.132

4.  Mosaicism in ATP1A3-related disorders: not just a theoretical risk.

Authors:  Marie Hully; Juliette Ropars; Laurence Hubert; Nathalie Boddaert; Marlene Rio; Mathieu Bernardelli; Isabelle Desguerre; Valerie Cormier-Daire; Arnold Munnich; Pascale de Lonlay; Louise Reilly; Claude Besmond; Nadia Bahi-Buisson
Journal:  Neurogenetics       Date:  2016-10-10       Impact factor: 2.660

5.  The Endless Expansion of the Phenotypic Spectrum of ATP1A3 Mutations: A True Diagnostic Challenge.

Authors:  Niccolò E Mencacci
Journal:  Mov Disord Clin Pract       Date:  2016-05-09

6.  Functional consequences of the CAPOS mutation E818K of Na+,K+-ATPase.

Authors:  Christian P Roenn; Melody Li; Vivien R Schack; Ian C Forster; Rikke Holm; Mads S Toustrup-Jensen; Jens P Andersen; Steven Petrou; Bente Vilsen
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

Review 7.  Paroxysmal Movement Disorders: Recent Advances.

Authors:  Zheyu Xu; Che-Kang Lim; Louis C S Tan; Eng-King Tan
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-11       Impact factor: 5.081

Review 8.  Diagnosis and Treatment of Alternating Hemiplegia of Childhood.

Authors:  Melanie Masoud; Lyndsey Prange; Jeffrey Wuchich; Arsen Hunanyan; Mohamad A Mikati
Journal:  Curr Treat Options Neurol       Date:  2017-02       Impact factor: 3.598

Review 9.  Novel pregnancy-triggered episodes of CAPOS syndrome.

Authors:  Irene J Chang; Margaret P Adam; Suman Jayadev; Thomas D Bird; Niranjana Natarajan; Ian A Glass
Journal:  Am J Med Genet A       Date:  2017-11-01       Impact factor: 2.802

10.  Progressive Brain Atrophy in Alternating Hemiplegia of Childhood.

Authors:  Masayuki Sasaki; Atsushi Ishii; Yoshiaki Saito; Shinichi Hirose
Journal:  Mov Disord Clin Pract       Date:  2017-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.